5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2-benzoxazole, 95.0%, 1g

C-[1-(4-Fluoro-benzenesulfonyl)-piperidin-4-yl]-methylamine hydrochloride, 95.0%, 100mg

(3S,4S)-1-(TERT-BUTOXYCARBONYL)-4-METHYLPYRROLIDINE-3-CARBOXYLIC ACID, 95.0%, 100mg

2-Chloro-7-methoxyquinoxaline, 95.0%, 100mg

Octylboronic acid, 95.0%, 5g

5,6,7,8-Tetrahydroimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 100mg

4-(1,2,2-Triphenylvinyl)benzaldehyde, 97.0%, 250mg

Sodium sulphate, min. 98.5%, Ph.Eur., anhydrous, 25 kg, plastic packaging.

Methyl 2-(bromomethyl)-6-cyanobenzoate, 95.0%, 1g

Di-tert-butyl(2'-methyl-[1,1'-biphenyl]-2-yl)phosphine, 97.0%, 5g

(S)-1-phenylethanaminium 2-((((3aS,4S,5R,7S,7aS)-octahydro-1H-4,7-methanoinden-5-yl)oxy)carbonyl)benzoate, 97%, 100mg

6-BROMO-5-CHLORO-3H-QUINAZOLIN-4-ONE, 95.0%, 1g

4-Bromo-5,6-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 97%, 1g